Other

National Defense Medical Center

Giant Force Technology Corporation

Chen-Wen Yao

Wen-Liang Chang

Hui Ling Tseng

I-Chuan Yen

Wan Ping Tseng

Tai Lin Tseng

Yin Yu Kuo

Ann Chen

An-Rong Lee

Wen-Hsin Huang

Chi-Hong Chu

Shuk-Man Ka

Li-Heng Pao

Kuo-Yuan Hwa

Chao-Wen Cheng

Jenn-Han Chen

Chiao-Ying Chien

Chien-Yi Pai

The present invention relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against influenza virus. The present invention also relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against drug-resistant influenza virus strains. The present invention is further related to a method for treating influenza in a subject, comprising administering to said subject an effective amount of mycophenolate mofetil or a pharmaceutically acceptable salt thereof.

Usage of mycophenolate mofetil or salt thereof in preparing drug for resisting against influenza virus

Disclosed is a method for inhibiting cancer cell growth in a subject in need thereof, comprising administering to the subject an effective amount of a compound from, wherein the compound is represented by formula (I): wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.

Method for inhibiting cancer cell growth

Disclosed is a compound isolated from, represented by formula I: wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.

Compound, extract isolated from antrodia camphorate, and method using the same

The present invention provides a use of compounds fromin manufacturing medicaments for treating kidney diseases, wherein the compounds is represented by formula (I): wherein Ris a hydrogen atom or acetyl group, Ris wherein the kidney disease is glomerulosclerosis or glomerulonephritis.

[object Object]

Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.

The present invention provides biomarkers for detecting kidney disease, selected from the oligonucleotide sequence, complementary sequence or derivatives, amino acid sequence or derivatives, fragment, variants, antibody of annexin A2 or S100A6 or combinations thereof. Moreover, the present invention also provides an assay kit and a method for kidney disease detecting, practically for the kidney disease resulting from acute tubular necrosis.

Method for diagnosing kidney disease comprising detecting the level of annexin A2

Growing community of inventors

Taipei, Taiwan

Chen-Wen Yao